📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Parallel evolution of Pseudomonas aeruginosa phage resistance and virulence loss in response to phage treatment in vivo and in vitro. (2022)

First Author: Castledine M
Attributed to:  Does CRISPR-Cas immunity limit the effectiveness of phage therapy? funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7554/elife.73679

PubMed Identifier: 35188102

Publication URI: http://europepmc.org/abstract/MED/35188102

Type: Journal Article/Review

Volume: 11

Parent Publication: eLife

ISSN: 2050-084X